These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3987786)

  • 21. Absorption and disposition of furosemide in congestive heart failure.
    Brater DC; Seiwell R; Anderson S; Burdette A; Dehmer GJ; Chennavasin P
    Kidney Int; 1982 Aug; 22(2):171-6. PubMed ID: 7132061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of furosemide in patients with acute pulmonary edema.
    Perez J; Sitar DS; Ogilvie RI
    Drug Metab Dispos; 1979; 7(6):383-7. PubMed ID: 43224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
    Smith DE; Lin ET; Benet LZ
    Drug Metab Dispos; 1980; 8(5):337-42. PubMed ID: 6107232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronopharmacological study of furosemide in human subjects.
    Tateishi T; Fujimura A; Miura T; Ebihara A
    Int J Clin Pharmacol Res; 1988; 8(6):401-7. PubMed ID: 3253217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.
    Alván G; Paintaud G; Eckernäs SA; Grahnén A
    Br J Clin Pharmacol; 1992 Jul; 34(1):47-52. PubMed ID: 1633067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
    Chaturvedi PR; O'Donnell JP; Nicholas JM; Shoenthal DR; Waters DH; Gwilt PR
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the diuretic response to oral and intravenous furosemide in "duretic-resistant" patients.
    Kelly MR; Blair AD; Forrey AW; Smidt NA; Cutler RE
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):1-9. PubMed ID: 401702
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers.
    Hildebrand M; Hellstern A; Hümpel M; Hellenbrecht D; Saller R
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):19-26. PubMed ID: 1974495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual administration of furosemide: new application of an old drug.
    Haegeli L; Brunner-La Rocca HP; Wenk M; Pfisterer M; Drewe J; Krähenbühl S
    Br J Clin Pharmacol; 2007 Dec; 64(6):804-9. PubMed ID: 17875188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
    J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K
    Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h.
    Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.
    MacFadyen RJ; Gorski JC; Brater DC; Struthers AD
    Br J Clin Pharmacol; 2004 May; 57(5):622-31. PubMed ID: 15089816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.